WHO naming stem · prefix · 27 listed names
vin-/-vin-
This page was written with AI.
vinca alkaloids
Where it sits in a name
WHO writes the stem as vin-/-vin-. It has 2 spellings or places: vin at the start of the name (vin…); vin inside the name, with letters before and after it (…vin…).
Of the 27 names WHO lists under it, 25 carry vin at the start of the name, 2 carry vin inside the name, with letters before and after it.
All 27 names WHO lists under vin-/-vin-
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 4 of 27 names appear in these lists: 3 in the US list (FDA Drugs@FDA) and 1 in the EU central list (EMA); 7 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- apovincamineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- brovincamineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinblastineEU (central) brands: none found
- vinburnineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vincamineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vincanolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vincantrilNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinconateNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vincristineUS brands: VINCRISTINE SULFATE PFS, MARQIBO KIT (discontinued in FDA listings), ONCOVIN (discontinued in FDA listings), VINCASAR PFS (discontinued in FDA listings), VINCREX (discontinued in FDA listings)EU (central) brands: none found
- vindeburnolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vindesineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinepidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinflunineUS brands: none foundEU (central) brands: Javlor
- vinformideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinfosiltineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinglycinateNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinleucinolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinleurosineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinmegallateNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinorelbineEU (central) brands: none found
- vinpocetineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinpolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinrosidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vintafolideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vintoperolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vintriptolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vinzolidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Names with these letters that are not vinca alkaloids
WHO lists these 3 names under vin-/-vin-, but says the stem is not used in its meaning here: group (b) of Part IV of the 2024 stem book, “INN in which the preferred stem has been used, but not in accordance with its definition”. The letters are marked where they sit; WHO’s note, where it gives one, is quoted as written. In these names, WHO’s definition of vin-/-vin- does not apply.
- vincofosWHO’s note: phosphate, anthelmintic
- vintiamol
- vinylbital
Decode another name
Decoded
vincanol
Listed INNCarries the WHO stem vin-/-vin-
- vin-/-vin-start of the nameWHO lists it hereWHO definition: vinca alkaloids
“vincanol” is an INN that WHO lists under vin-/-vin- in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of vin-/-vin- (Part II B) and the 27 names (Part IV, group (a)), and the 3 not in accordance with it (group (b)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.